Apple Tree says its biotechs face ‘imminent collapse’; Advocates urge J&J to proceed with eye gene therapy; AbbVie buys in vivo CAR-T maker Capstan; and more
Happy July 4th weekend! We’ve got a condensed version of Endpoints Weekly for you this week, so let’s dive right into the biggest stories. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
